Condition
Oncogene-addicted Non Small Cell Lung Cancer
Total Trials
2
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Recruiting1
Enrolling By Invitation1
Clinical Trials (2)
Showing 2 of 2 trials
NCT07122882Enrolling By InvitationPrimary
Integrated Genomics in Oncogene-driven NSCLC With Acquired Resistance
NCT07008742RecruitingPrimary
Feasibility Study of Tissue and Blood Collection in Oncogene-addicted and Neoadjuvantly Treated Non Small Cell Lung Cancer
Showing all 2 trials